Anti-GDPD1 monoclonal antibody

Pre-made anti-GDPD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GDPD1/GDPD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0897-Ab-1/ GM-Tg-hg-IP0897-Ab-2Anti-Human GDPD1 monoclonal antibodyHuman
GM-Tg-rg-IP0897-Ab-1/ GM-Tg-rg-IP0897-Ab-2Anti-Rat GDPD1 monoclonal antibodyRat
GM-Tg-mg-IP0897-Ab-1/ GM-Tg-mg-IP0897-Ab-2Anti-Mouse GDPD1 monoclonal antibodyMouse
GM-Tg-cynog-IP0897-Ab-1/ GM-Tg-cynog-IP0897-Ab-2Anti-Cynomolgus/ Rhesus macaque GDPD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0897-Ab-1/ GM-Tg-felg-IP0897-Ab-2Anti-Feline GDPD1 monoclonal antibodyFeline
GM-Tg-cang-IP0897-Ab-1/ GM-Tg-cang-IP0897-Ab-2Anti-Canine GDPD1 monoclonal antibodyCanine
GM-Tg-bovg-IP0897-Ab-1/ GM-Tg-bovg-IP0897-Ab-2Anti-Bovine GDPD1 monoclonal antibodyBovine
GM-Tg-equg-IP0897-Ab-1/ GM-Tg-equg-IP0897-Ab-2Anti-Equine GDPD1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0897-Ab-1/ GM-Tg-hg-IP0897-Ab-2; GM-Tg-rg-IP0897-Ab-1/ GM-Tg-rg-IP0897-Ab-2;
GM-Tg-mg-IP0897-Ab-1/ GM-Tg-mg-IP0897-Ab-2; GM-Tg-cynog-IP0897-Ab-1/ GM-Tg-cynog-IP0897-Ab-2;
GM-Tg-felg-IP0897-Ab-1/ GM-Tg-felg-IP0897-Ab-2; GM-Tg-cang-IP0897-Ab-1/ GM-Tg-cang-IP0897-Ab-2;
GM-Tg-bovg-IP0897-Ab-1/ GM-Tg-bovg-IP0897-Ab-2; GM-Tg-equg-IP0897-Ab-1/ GM-Tg-equg-IP0897-Ab-2
Products NameAnti-GDPD1 monoclonal antibody
Formatmab
Target NameGDPD1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GDPD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0897-Ag-1Recombinant multi-species GDPD1/ GDE4 protein


    Target information

    Target IDGM-IP0897
    Target NameGDPD1
    Gene ID284161,66569,303407,711332,491117,101081586,615890,100057236
    Gene Symbol and Synonyms2610020H15Rik,GDE4,GDPD1,RGD1311813
    Uniprot AccessionQ8N9F7,Q0VGK4
    Uniprot Entry NameGDPD1_HUMAN,GDPD1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000153982
    Target ClassificationN/A

    The target: GDPD1, gene name: GDPD1, also named as GDE4. This gene encodes a member of the glycerophosphodiester phosphodiesterase family of enzymes that catalyze the hydrolysis of deacylated glycerophospholipids to glycerol phosphate and alcohol. The encoded protein is localized to the cytoplasm and concentrates near the perinuclear region. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.